Contract 36F79723D0071
Bioxcel Therapeutics, Inc. · Department Of Veterans Affairs · July 29, 2024
Bioxcel Therapeutics, Inc. was awarded a federal contract by Department Of Veterans Affairs on July 29, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 10, 2025. If all options are exercised, the contract could reach $2.23 million.
Contract details
- PIID
- 36F79723D0071
- Award type
- Fss
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- July 29, 2024
- Latest action
- December 10, 2025
Description
2026 PUBLIC LAW PRICING UPDATE
Modification timeline
-
December 10, 2025Mod P00010 · Supplemental Agreement For Work Within Scope$0
-
December 9, 2024Mod P00009$0
-
July 29, 2024Mod P00008 · Other Administrative ActionFSS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79723D0071?
Contract 36F79723D0071 is a federal contract awarded to Bioxcel Therapeutics, Inc. by Department Of Veterans Affairs on July 29, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36F79723D0071?
Bioxcel Therapeutics, Inc. won contract 36F79723D0071 from Department Of Veterans Affairs.
How much is contract 36F79723D0071 worth?
Contract 36F79723D0071 has obligated $0 to date but carries a potential ceiling of $2.23 million if fully funded and all options are exercised.